Dopamine, a neurotransmitter, influences the immune system

被引:274
作者
Basu, S
Dasgupta, PS
机构
[1] Chittaranjan Natl Canc Inst, Signal Transduct & Biogen Amines Lab, Kolkata 700026, W Bengal, India
[2] Chittaranjan Natl Canc Inst, Dept Med Oncol, Kolkata 700026, W Bengal, India
关键词
dopamine; effector cells; immunity;
D O I
10.1016/S0165-5728(99)00176-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dopamine (DA) is a monoamine neurotransmitter of both central and peripheral nervous system. Its role in the neural-immune communication has been discussed in the present review. Results reveal that in vivo damage or stimulation of specific central dopaminergic system suppresses or enhances functional activities of the immune effector cells. The possible influences of other immunomodulators of the brain by altering brain DA may be the underlying mechanism, Direct effects of DA on the immune effector cells are also contradictory, it is suppressive in vitro, while in pharmacological doses, it is mostly stimulatory in vivo. The possible mechanisms have been discussed. Lastly, future areas of relevance on DA and immunity have been highlighted to advance our knowledge regarding DA as an immune regulator. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:113 / 124
页数:12
相关论文
共 128 条
  • [1] PSYCHONEUROIMMUNOLOGY - INTERACTIONS BETWEEN THE NERVOUS-SYSTEM AND THE IMMUNE-SYSTEM
    ADER, R
    COHEN, N
    FELTEN, D
    [J]. LANCET, 1995, 345 (8942) : 99 - 103
  • [2] INTERACTIONS BETWEEN THE BRAIN AND THE IMMUNE-SYSTEM
    ADER, R
    FELTEN, D
    COHEN, N
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1990, 30 : 561 - 602
  • [3] Dopamine β-hydroxylase deficiency impairs cellular immunity
    Alaniz, RC
    Thomas, SA
    Perez-Melgosa, M
    Mueller, K
    Farr, AG
    Palmiter, RD
    Wilson, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 2274 - 2278
  • [4] INTERLEUKIN-2 MODULATES EVOKED RELEASE OF [H-3] DOPAMINE IN RAT CULTURED MESENCEPHALIC CELLS
    ALONSO, R
    CHAUDIEU, I
    DIORIO, J
    KRISHNAMURTHY, A
    QUIRION, R
    BOKSA, P
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (04) : 1284 - 1290
  • [5] Production of interferon-gamma in families with multiple occurrence of schizophrenia
    Arolt, V
    Weitzsch, C
    Wilke, I
    Nolte, A
    Pinnow, M
    Rothermundt, M
    Kirchner, H
    [J]. PSYCHIATRY RESEARCH, 1997, 66 (2-3) : 145 - 152
  • [6] ALTERATIONS OF SOMATOSTATIN AND ITS MODULATION BY LEVODOPA IN MPTP-TREATED MOUSE-BRAIN
    ASANUMA, M
    OGAWA, N
    SORA, YH
    PONGDHANA, K
    HABA, K
    MORI, A
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 100 (1-2) : 155 - 160
  • [7] BALK JH, 1995, NATURE, V377, P424
  • [8] Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine?
    Barbanti, P
    Bronzetti, E
    Ricci, A
    Cerbo, R
    Fabbrini, G
    Buzzi, MG
    Amenta, F
    Lenzi, GL
    [J]. NEUROSCIENCE LETTERS, 1996, 207 (02) : 73 - 76
  • [9] Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes
    Barili, P
    Bronzetti, E
    Felici, L
    Ferrante, F
    Ricci, A
    Zaccheo, D
    Amenta, F
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) : 45 - 50
  • [10] ENHANCED TUMOR-GROWTH IN BRAIN DOPAMINE-DEPLETED MICE FOLLOWING 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) TREATMENT
    BASU, S
    DASGUPTA, PS
    CHOWDHURY, JR
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1995, 60 (1-2) : 1 - 8